Boston (dbTechno) – Novavax Inc. has released the first results of human safety trials of their new experimental bird flu vaccine. What they have found is that it appears both safe and effective.
The new vaccine helps protect people against the H5N1 bird flu virus.
Novavax stated in the results that their new bird flu vaccine was just as effective as any other vaccine currently on the market, and is safe enough to move foward.
The new bird flu vaccine from Novavax is different than others, as it is grown in lab dishes, and uses virus that looks and acts just like the H5N1 strain of the bird flu.
The virus being grown in the lab dish is not the actual virus, but it makes your body believe that it is.
The results of the trial show that the bird flu vaccine will be very compeitive against other vaccines.
Novavax believes that they will be able to use this process to make their vaccine faster than others.
Facebook comments: